| 1 |
Ma_Y_2012 |
Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach |
Ma, Ying; Wang, Shu-Qing; Xu, Wei-Ren; Wang, Run-Ling; Chou, Kuo-Chen |
2012 |
2012-06-07 |
COMM-USE |
N |
PMC3369836 |
22685582.0 |
10.1371/journal.pone.0038546 |
dy7djsah |
0.966258 |
|
Liu_L_2013, Ahmadian_2013, Lin_S_2019 |
| 2 |
Liu_L_2013 |
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics |
Liu, Lei; Ma, Ying; Wang, Run-Ling; Xu, Wei-Ren; Wang, Shu-Qing; Chou, Kuo-Chen |
2013 |
2013-04-08 |
PMC |
N |
PMC3623550 |
23630413.0 |
10.2147/dddt.s42113 |
icwhpbpj |
0.940291 |
|
Ma_Y_2012 |
| 3 |
Kanasaki_2019 |
Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon |
Kanasaki, Keizo; Kawakita, Emi; Koya, Daisuke |
2019 |
2019-05-16 |
COMM-USE |
N |
PMC6531852 |
31156426.0 |
10.3389/fphar.2019.00476 |
1s44e2le |
0.804036 |
|
Beckers_2017, Lin_S_2019 |
| 4 |
Tieku_1992 |
Inhibition of aminopeptidases N, A and W A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme |
Tieku, Stephen; Hooper, Nigel M. |
1992 |
1992-11-03 |
PMC |
N |
PMC7111144 |
1360211.0 |
10.1016/0006-2952(92)90065-q |
ll6f6brf |
0.753765 |
Deaton_2008 |
Noble_2000, Danziger_2007 |
| 5 |
Lin_S_2019 |
The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo |
Lin, Shian-Ren; Chang, Chia-Hsiang; Tsai, May-Jwan; Cheng, Henrich; Chen, Jian-Chyi; Leong, Max K.; Weng, Ching-Feng |
2019 |
2019-09-19 |
NONCOMM |
N |
PMC6753520 |
31555430.0 |
10.1177/2040622319875305 |
b3o0vtob |
0.749421 |
Kanasaki_2019, Mulvihill_2014, Gong_2015 |
Mulvihill_2014, Kanasaki_2019 |
| 6 |
Zhong_2015 |
Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials |
Zhong, Jixin; Gong, Quan; Goud, Aditya; Srinivasamaharaj, Srividya; Rajagopalan, Sanjay |
2015 |
2015-05-14 |
COMM-USE |
N |
PMC4446505 |
26075284.0 |
10.1155/2015/606031 |
3rukouk3 |
0.681258 |
Gong_2015 |
Panchapakesan_2015, Lin_S_2019 |
| 7 |
Yun_Y_2014 |
Kimchi Methanol Extract and the Kimchi Active Compound, 3′-(4′-Hydroxyl-3′,5′-Dimethoxyphenyl)Propionic Acid, Downregulate CD36 in THP-1 Macrophages Stimulated by oxLDL |
Yun, Ye-Rang; Kim, Hyun-Ju; Song, Yeong-Ok |
2014 |
2014-08-01 |
PMC |
N |
PMC4126270 |
25010893.0 |
10.1089/jmf.2013.2943 |
m4paktyf |
0.598447 |
|
|
| 8 |
Mulvihill_2014 |
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors |
Mulvihill, Erin E.; Drucker, Daniel J. |
2014 |
2014-12-01 |
PMC |
N |
PMC7108477 |
25216328.0 |
10.1210/er.2014-1035 |
8emckxv0 |
0.578242 |
|
Lin_S_2019, Beckers_2017 |
| 9 |
Zhong_2016 |
DPP4 Inhibition: Insights From the Bench and Recent Clinical Studies |
Zhong, Jixin; Kankanala, Saumya; Rajagopalan, Sanjay |
2016 |
2016-10-01 |
PMC |
N |
PMC5147592 |
27472408.0 |
10.1097/mol.0000000000000340 |
6ruond0m |
0.576089 |
Gong_2015 |
Zhong_2015, Panchapakesan_2015, Beckers_2017, Kanasaki_2019 |
| 10 |
Ahmadian_2013 |
PPARγ signaling and metabolism: the good, the bad and the future |
Ahmadian, Maryam; Suh, Jae Myoung; Hah, Nasun; Liddle, Christopher; Atkins, Annette R; Downes, Michael; Evans, Ronald M |
2013 |
2013-05-01 |
PMC |
N |
PMC3870016 |
23652116.0 |
10.1038/nm.3159 |
nd99ibso |
0.538172 |
|
Ma_Y_2012, Kanasaki_2019 |
| 11 |
Gong_2015 |
Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function |
Gong, Quan; Rajagopalan, Sanjay; Zhong, Jixin |
2015 |
2015-10-15 |
PMC |
N |
PMC7114201 |
26142202.0 |
10.1016/j.ijcard.2015.06.076 |
8vj0t57e |
0.527436 |
Zhong_2015, Zablocki_2011 |
Zhong_2015, Panchapakesan_2015, Zhong_2016, Kanasaki_2019 |
| 12 |
Kanasaki_2018 |
The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin |
Kanasaki, Keizo |
2018 |
2018-02-28 |
COMM-USE |
N |
PMC5828949 |
29491123.0 |
10.1042/cs20180031 |
61t4e1eg |
0.486677 |
Shi_S_2016, Gong_2015, Kanasaki_2019 |
Panchapakesan_2015, Lin_S_2019 |
| 13 |
Ma_Y_2020 |
PPARγ and Its Agonists in Chronic Kidney Disease |
Ma, Yuhua; Shi, Manman; Wang, Yuxin; Liu, Jian |
2020 |
2020-02-25 |
COMM-USE |
N |
PMC7060840 |
32158560.0 |
10.1155/2020/2917474 |
vbs6hn3a |
0.451035 |
Zablocki_2011 |
Panchapakesan_2015, Wolke_2016, Beckers_2017 |
| 14 |
Shi_S_2016 |
Dipeptidyl peptidase-4 and kidney fibrosis in diabetes |
Shi, Sen; Koya, Daisuke; Kanasaki, Keizo |
2016 |
2016-02-13 |
COMM-USE |
N |
PMC4752740 |
26877767.0 |
10.1186/s13069-016-0038-0 |
psuqq87n |
0.430630 |
Gong_2015, Soler_2008, Panchapakesan_2015, Zhong_2015 |
Panchapakesan_2015, Kanasaki_2018, Beckers_2017 |
| 15 |
Rao_X_2019 |
Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways |
Rao, Xiaoquan; Zhao, Shi; Braunstein, Zachary; Mao, Hong; Razavi, Michael; Duan, Lihua; Wei, Yingying; Toomey, Amelia C.; Rajagopalan, Sanjay; Zhong, Jixin |
2019 |
2019-02-07 |
None |
N |
PMC6441950 |
30738832.0 |
10.1016/j.ebiom.2019.01.065 |
1n7xjjd5 |
0.427527 |
|
Beckers_2017, Kondo_2018 |
| 16 |
Ramya_2020 |
Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules |
Ramya, Krishnappa; Suresh, Ramalingam; Kumar, Honnavalli Yogish; Kumar, B.R. Prashantha; Murthy, N.B. Sridhara |
2020 |
2020-03-28 |
PMC |
N |
|
|
10.1016/j.bmc.2020.115466 |
3bi01dvn |
0.424000 |
Zhao_2008, Zablocki_2011, Soler_2008, Tikellis_2012, Jones_2008 |
Bradford_2010, Patel_2016, Sparks_2014, Lambert_2008 |
| 17 |
Deaton_2008 |
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite |
Deaton, David N.; Gao, Enoch N.; Graham, Kevin P.; Gross, Jeffrey W.; Miller, Aaron B.; Strelow, John M. |
2008 |
2008-01-15 |
PMC |
N |
PMC7126659 |
18078750.0 |
10.1016/j.bmcl.2007.11.048 |
gic43uwz |
0.384552 |
Zhao_2008, Tikellis_2012 |
|
| 18 |
Schrom_2017 |
Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA |
Schrom, Eva; Huber, Maja; Aneja, Manish; Dohmen, Christian; Emrich, Daniela; Geiger, Johannes; Hasenpusch, Günther; Herrmann-Janson, Annika; Kretzschmann, Verena; Mykhailyk, Olga; Pasewald, Tamara; Oak, Prajakta; Hilgendorff, Anne; Wohlleber, Dirk; Hoymann, Heinz-Gerd; Schaudien, Dirk; Plank, Christian; Rudolph, Carsten; Kubisch-Dohmen, Rebekka |
2017 |
2017-04-13 |
None |
N |
PMC5423349 |
28624211.0 |
10.1016/j.omtn.2017.04.006 |
tulmnb32 |
0.353477 |
|
Gembardt_2005, Xiao_2014 |